Symbol="SLNO"
AssetType="Common Stock"
Name="Soleno Therapeutics Inc"
Description="Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of rare diseases. The company is headquartered in Redwood City, California."
CIK="1484565"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS"
Address="1235 RADIO ROAD, SUITE 110, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="36269400"
EBITDA="-24686000"
PERatio="None"
PEGRatio="0"
BookValue="0.323"
DividendPerShare="0"
DividendYield="0"
EPS="-2.99"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.537"
ReturnOnEquityTTM="-1.835"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.99"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.494"
EVToRevenue="-"
EVToEBITDA="0.516"
Beta="0.0888"
num_52WeekHigh="6.2"
num_52WeekLow="0.85"
num_50DayMovingAverage="4.668"
num_200DayMovingAverage="2.588"
SharesOutstanding="8168800"
DividendDate="2017-10-06"
ExDividendDate="None"
symbol="SLNO"
open="4.25"
high="4.63"
low="4.25"
price="4.44"
volume="33751.00"
latest_trading_day="2023-07-07"
previous_close="4.38"
change="0.06"
change_percent="1.3699%"
aroon_positive_momentum_days="91"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="91"
Volume_recent_avg="82896"
Change_recent_avg="0.02"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="0.67"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="91"
Aroon_momentum_negative="9"
image_negative_thumbnail_id_1="514"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_negative_thumbnail_id_2="160"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0016.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="651"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_positive_thumbnail_id_2="952"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0114.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
